Pathophysiological Mechanisms of Chemical-Induced Acute Lung Injury
Pathophysiological Mechanisms of Chemical-Induced Acute Lung Injury
批准号:
10708438
负责人:
George Douglas Leikauf
金额:
$49.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-20 至 2026-07-31
关键词:
129X1/SvJ MouseAccidentsAcroleinAcute Lung InjuryAcute Respiratory Distress SyndromeAgeAirAlveolarBronchoalveolar LavageCarbonCell DeathCellsCessation of lifeChemical WeaponsChemicalsComplexCritical PathwaysDevelopmentDiagnosisDisease ProgressionEndotheliumEtiologyEventExperimental ModelsExposure toEyeFemaleFreezingGasesGenetic Predisposition to DiseaseGlobal WarmingGoalsHazardous ChemicalsHistopathologyInfiltrationInhalationInjuryInvestigationIrritantsKnowledgeLipidsLungMeasuresMechanical ventilationMethodsMolecularMolecular AnalysisMolecular TargetMouse StrainsMusNeutrophil InfiltrationOutcomes ResearchOxygenPartial PressurePathologicPathway interactionsPatientsPhosgenePredispositionPreventionProteinsPublic HealthPulmonary EdemaReactionResearchResistanceResolutionRespiratory SystemRisk FactorsSM/J MouseSeveritiesSmokeStructureTerrorismTestingTherapeutic InterventionTimeTranscriptWildfireWorld War Ialveolar epitheliumdesigninnovationinsightirritationlipidomicslung injurymacromoleculemalemetabolomicsmortalitymultiple omicsresearch clinical testingresponsesexsingle-cell RNA sequencingskin burnsmoke inhalationtherapeutically effectivetherapy developmenttranscriptomics
中文摘要
项目摘要
这个应用程序的总体目标是确定导致病理性疾病的关键事件的顺序。
丙烯醛和光气吸入后引起的进展。化学性急性肺损伤(CIALI)是一种
急性呼吸窘迫综合征(ARDS)。ARDS的特征是肺泡屏障功能丧失
这导致蛋白质和嗜中性粒细胞浸润到肺泡气隙中的增加。目前,ARDS治疗
主要限于有管理的机械通气,死亡率仍然很高。死亡率受以下因素影响
患者的性别、年龄和遗传易感性,这可以在小鼠中进行实验建模。CIALI的主要风险
因素是烟雾吸入,烟雾中的主要刺激物是丙烯醛。死亡可以是立即的或延迟的,
这是一种复杂的细胞和肺部反应,随着时间的推移而发展,并决定了损伤的严重程度。
另一种能引起迟发性肺水肿的化学物质是光气,
第一次世界大战的武器目前,尚不清楚丙烯醛和光气是否通过相同的方法产生CIALI。
重叠机制或每种化学品特有的机制。开发有效的治疗方法
干预措施,需要更多的研究来了解疾病进展和损伤解决机制
潜在的损伤严重程度和死亡率。本提案的具体目标如下:1.确定
对丙烯醛诱导的急性肺损伤的敏感性和抵抗性的时间事件,2.描述关键途径
在丙烯醛诱导的CIALI进展和解决使用多组学分析,和3。比较和对比
从β-内酰胺酶基因诱导的CIALI到丙烯醛诱导的CIALI的进展。详细的时间进程分析将
评价支气管肺泡灌洗、肺组织病理学、空间脂质组学、空间代谢组学和单细胞
和丙烯醛或光气暴露后的空间转录组学。菌株特异性和性别特异性反应将
研究了确定控制疾病进展和消退的关键病理事件的顺序
丙烯醛和光气引起的急性肺损伤可能为发展
疗法
英文摘要
Project Summary
The overall goal of this application is to determine the sequence of key events that leads to the pathological
progression elicited after acrolein and phosgene inhalation. Chemically-induced acute lung injury (CIALI) is a
form of acute respiratory distress syndrome (ARDS). ARDS is characterized by loss of alveolar barrier function
that leads to increased protein and neutrophil infiltration into the alveolar air space. Currently, ARDS therapy is
mainly limited to managed mechanical ventilation, and the mortality rate remains high. Mortality is influenced by
sex, age, and genetic susceptibility in patients, which can be experimentally modeled in mice. A major CIALI risk
factor is smoke inhalation and the main irritant in smoke is acrolein. Death can be immediate or delayed resulting
from a complex cellular and pulmonary responses that progress with time and dictate the severity of the injury.
Another chemical that can induce delayed pulmonary edema is phosgene, which was develop as a chemical
weapon in World War I. Currently, it is unknown whether acrolein and phosgene produce CIALI by the same
overlapping mechanisms or by mechanisms unique to each chemical. To develop effective therapeutic
interventions, more studies are needed to understand the disease-progression and injury-resolution mechanisms
underlying severity of injury and mortality. This proposal has the following Specific Aims: 1. Determine the
temporal events of sensitivity and resistance to acrolein-induced acute lung injury, 2. Delineate critical pathways
in acrolein-induced CIALI progression and resolution using multiomic analyses, and 3. Compare and contrast
the progression of phosgene-induced CIALI to that of acrolein-induced CIALI. Detailed time course analyses will
evaluate bronchoalveolar lavage, lung histopathology, spatial lipidomics, spatial metabolomics and single-cell
and spatial transcriptomics following acrolein or phosgene exposure. Strain- and sex-specific responses will be
investigated. Determining the sequence of key pathological events controlling the progression and resolution of
acute lung injury elicited by acrolein and phosgene should provide a mechanistic basis for the development of
therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving our mechanistic understanding of Electronic-cigarette, or vaping, product use-associated lung injury
-
批准号:10115186
-
项目类别:
-
资助金额:$11.97万
-
财政年份:2020
-
负责人:George Douglas Leikauf
-
依托单位:
Countermeasure Therapeutics for Acute Lung Injury
-
批准号:9207983
-
项目类别:
-
资助金额:$23.14万
-
财政年份:2016
-
负责人:George Douglas Leikauf
-
依托单位:
Countermeasure Therapeutics for Acute Lung Injury
-
批准号:9357593
-
项目类别:
-
资助金额:$19.46万
-
财政年份:2016
-
负责人:George Douglas Leikauf
-
依托单位:
Role of Metalloproteinases in Mucin Overproduction in COPD
-
批准号:7461274
-
项目类别:
-
资助金额:$35.32万
-
财政年份:2008
-
负责人:George Douglas Leikauf
-
依托单位:
Role of Metalloproteinases in Mucin Overproduction in COPD
-
批准号:7783818
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2008
-
负责人:George Douglas Leikauf
-
依托单位:
Role of Metalloproteinases in Mucin Overproduction in COPD
-
批准号:7581036
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2008
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical-Induced Acute Lung Injury
-
批准号:8144632
-
项目类别:
-
资助金额:$75.33万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical-Induced Acute Lung Injury
-
批准号:8323241
-
项目类别:
-
资助金额:$74.44万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical-Induced Acute Lung Injury
-
批准号:8485604
-
项目类别:
-
资助金额:$73.0万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical -Induced Acute Lung Injury
-
批准号:7662563
-
项目类别:
-
资助金额:$70.5万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical -Induced Acute Lung Injury
-
批准号:7498521
-
项目类别:
-
资助金额:$68.94万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical -Induced Acute Lung Injury
-
批准号:7293573
-
项目类别:
-
资助金额:$73.86万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical-Induced Acute Lung Injury
-
批准号:8901168
-
项目类别:
-
资助金额:$69.95万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical-Induced Acute Lung Injury
-
批准号:8694032
-
项目类别:
-
资助金额:$71.55万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical -Induced Acute Lung Injury
-
批准号:7224694
-
项目类别:
-
资助金额:$77.22万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical -Induced Acute Lung Injury
-
批准号:7858079
-
项目类别:
-
资助金额:$71.4万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Growth Factor Protection in Acute Lung Injury
-
批准号:7159406
-
项目类别:
-
资助金额:$34.76万
-
财政年份:2005
-
负责人:George Douglas Leikauf
-
依托单位:
Growth Factor Protection in Acute Lung Injury
-
批准号:7535986
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2005
-
负责人:George Douglas Leikauf
-
依托单位:
Growth Factor Protection in Acute Lung Injury
-
批准号:7049989
-
项目类别:
-
资助金额:$35.98万
-
财政年份:2005
-
负责人:George Douglas Leikauf
-
依托单位:
Growth Factor Protection in Acute Lung Injury
-
批准号:7329821
-
项目类别:
-
资助金额:$35.73万
-
财政年份:2005
-
负责人:George Douglas Leikauf
-
依托单位:
海外基金